Status:
COMPLETED
Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia
Lead Sponsor:
Fakeeh College for Medical Sciences
Conditions:
Stigmatization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Backgrounds: Research evidence suggests that people diagnosed with schizophrenia (PDwS) experience higher level of stigma compared with other forms of mental illness, and they are prone to internalize...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- Adults aged 18 or over diagnosed with schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) (American Psychiatric Association, 2013).
- All participants had to be able to read and write English or Arabic
- Willing and able to consent.
- Exclusion criteria were:
- \- People diagnosed with schizophrenia who had a learning disability, with known organic mental disorder, substance abuse
Exclusion
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2018
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT04087954
Start Date
November 1 2017
End Date
December 22 2018
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health
Amman, Jordan, 00962